These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
253 related items for PubMed ID: 2175625
1. Renal effects of atrial natriuretic peptide during dopamine infusion. Hirata Y, Fukui K, Hayakawa H, Suzuki E, Sugimoto T, Kimura K, Matsuoka H, Sugimoto T. Am J Hypertens; 1990 Nov; 3(11):866-9. PubMed ID: 2175625 [Abstract] [Full Text] [Related]
2. Nephrogenous cyclic GMP production during NaCl loading and ANP infusion. Hirata Y, Fukui K, Hayakawa H, Namba S, Ishimitsu T, Sugimoto T, Kimura K, Matsuoka H, Sugimoto T. Jpn Heart J; 1990 Nov; 31(6):809-16. PubMed ID: 1964701 [Abstract] [Full Text] [Related]
5. [The significance of atrial natriuretic polypeptide in the cause of essential hypertension]. Mori K. Nihon Naibunpi Gakkai Zasshi; 1991 Jul 20; 67(7):796-810. PubMed ID: 1653713 [Abstract] [Full Text] [Related]
6. Four-hour atrial natriuretic peptide infusion in conscious rats: effects on urinary volume, sodium, and cyclic GMP. Campbell HT, Lightfoot BO, Sklar AH. Proc Soc Exp Biol Med; 1988 Dec 20; 189(3):317-24. PubMed ID: 2849771 [Abstract] [Full Text] [Related]
7. Permissive role of dopamine in renal action of ANP in volume-expanded rats. Katoh T, Sophasan S, Kurokawa K. Am J Physiol; 1989 Aug 20; 257(2 Pt 2):F300-9. PubMed ID: 2527470 [Abstract] [Full Text] [Related]
14. Renal and vascular effects of C-type and atrial natriuretic peptides in humans. Pham I, Sediame S, Maistre G, Roudot-Thoraval F, Chabrier PE, Carayon A, Adnot S. Am J Physiol; 1997 Oct 20; 273(4):R1457-64. PubMed ID: 9362312 [Abstract] [Full Text] [Related]
15. Blunted vascular and renal effects of exogenous atrial natriuretic peptide in patients with cushing's disease. Sala C, Ambrosi B, Morganti A. J Clin Endocrinol Metab; 2001 May 20; 86(5):1957-61. PubMed ID: 11344191 [Abstract] [Full Text] [Related]
16. The dopamine receptor antagonist haloperidol blocks natriuretic but not hypotensive effects of the atrial natriuretic factor. Hansell P, Fasching A, Sjöquist M, Andén NE, Ulfendahl HR. Acta Physiol Scand; 1987 Jul 20; 130(3):401-7. PubMed ID: 2957892 [Abstract] [Full Text] [Related]
17. Blunted renal responses to atrial natriuretic peptide and its reversal by unclipping in one-kidney, one clip Goldblatt hypertensive rats. Huang WC, Wu JN. J Hypertens; 1997 Feb 20; 15(2):181-9. PubMed ID: 9469794 [Abstract] [Full Text] [Related]
18. Comparison of renal actions of urodilatin and atrial natriuretic peptide. Hildebrandt DA, Mizelle HL, Brands MW, Hall JE. Am J Physiol; 1992 Mar 20; 262(3 Pt 2):R395-9. PubMed ID: 1313650 [Abstract] [Full Text] [Related]
19. Effects of atrial natriuretic peptide on urinary kallikrein excretion and renal function in rats. Lòpez C, Jimenez W, Arroyo V, La Villa G, Martinez-Pardo A, Gaya J, Rivera F. Eur J Pharmacol; 1989 Sep 01; 168(1):1-6. PubMed ID: 2531092 [Abstract] [Full Text] [Related]
20. Effects of atrial natriuretic peptide on renal function after cardiac surgery and in cyclosporine-treated heart transplant recipients. Valsson F, Ricksten SE, Hedner T, Zäll S, William-Olsson EB, Lundin S. J Cardiothorac Vasc Anesth; 1994 Aug 01; 8(4):425-30. PubMed ID: 7948799 [Abstract] [Full Text] [Related] Page: [Next] [New Search]